Noninferiority study evaluating dexamethasone (DEX)-sparing regimens administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) caused by high-dose cisplatin.

被引：0
|
作者：
Celio, Luigi
Bonizzoni, Erminio
Bria, Emilio
机构：
[1] Desenzano Garda Hosp, Oncol Unit, ASST Garda, Brescia, Italy
[2] Univ Milan, Fac Med & Surg, Sect Med Stat Biometry & Epidemiol GA Maccacaro, Dept Clin Sci & Commun, Milan, Italy
[3] Univ Cattolica Sacro Cuore, IRCCS, Fdn Policlin Univ Agostino Gemelli, Med Oncol,Comprehens Canc Ctr, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.12093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12093
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)
    Navari, Rudolph M.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 9 : 155 - 161
  • [2] Phase III study of NEPA, a fixed combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV).
    Zhang, Li
    Lu, Shun
    Feng, Ji Feng
    Dechaphunkul, Arunee
    Chessari, Salvatore
    Lanzarotti, Corinna
    Jordan, Karin
    Aapro, Matti S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study
    Celio, Luigi
    Cortinovis, Diego
    Cogoni, Alessio Aligi
    Cavanna, Luigi
    Martelli, Olga
    Carnio, Simona
    Collova, Elena
    Bertolini, Federica
    Petrelli, Fausto
    Cassano, Alessandra
    Chiari, Rita
    Zanelli, Francesca
    Pisconti, Salvatore
    Vittimberga, Isabella
    Letizia, Antonietta
    Misino, Andrea
    Gernone, Angela
    Bonizzoni, Erminio
    Pilotto, Sara
    De Placido, Sabino
    Bria, Emilio
    ONCOLOGIST, 2021, 26 (10): : E1854 - E1861
  • [4] Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Baron-Hay, Sally
    Aapro, Matti
    Bernareggi, Alberto
    Schwartzberg, Lee
    SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1309 - 1317
  • [5] Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Sally Baron-Hay
    Matti Aapro
    Alberto Bernareggi
    Lee Schwartzberg
    Supportive Care in Cancer, 2019, 27 : 1309 - 1317
  • [6] Netupitant/palonosetron (NEPA) for prevention of delayed chemotherapy-induced nausea and vomiting (CINV) in multiple cycles of chemotherapy.
    Schwartzberg, Lee Steven
    Gralla, Richard J.
    Kashef, Kimia
    Rugo, Hope
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [7] Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting
    Lorusso, Vito
    Karthaus, Meinolf
    Aapro, Matti
    FUTURE ONCOLOGY, 2015, 11 (04) : 565 - 577
  • [8] NEPA, AN ORAL FIXED COMBINATION OF NETUPITANT AND PALONOSETRON, IS A COST-EFFECTIVE INTERVENTION FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN GERMANY AND GREECE
    Bourhis, F.
    Eriksson, J.
    Ruffo, P.
    D'Agostino, P.
    Turini, M.
    VALUE IN HEALTH, 2018, 21 : S43 - S44
  • [9] Prevention of chemotherapy-induced nausea and vomiting (CINV) over repeated chemotherapy cycles: Results of a phase 3 trial of NEPA, a fixed oral dose combination of netupitant and palonosetron
    Gralla, R. J.
    Bosnjak, S. M.
    Balser, C.
    Rizzi, G.
    Borroni, M. E.
    Rossi, G.
    Jordan, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S267 - S267
  • [10] NETUPITANT AND PALONOSETRON (NEPA), IS A COST-EFFECTIVE INTERVENTION FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN SINGAPORE
    Lim, S. W.
    Loh, K. W. J.
    Boisseau, S.
    Ho, W. T.
    Qasuri, M.
    D'agostino, P.
    Turini, M. M.
    Bourhis, F.
    Eriksson, J.
    Hadjiat, Y.
    VALUE IN HEALTH, 2019, 22 : S475 - S476
12345